Suppr超能文献

脓毒性休克逆转后院内死亡:泰国最大国家三级转诊中心脓毒性休克幸存者院内死亡的回顾性分析。

In-Hospital Death after Septic Shock Reversal: A Retrospective Analysis of In-Hospital Death among Septic Shock Survivors at Thailand's Largest National Tertiary Referral Center.

机构信息

1Division of Critical Care, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

2Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

出版信息

Am J Trop Med Hyg. 2021 Jan;104(1):395-402. doi: 10.4269/ajtmh.20-0896.

Abstract

Advances in sepsis resuscitation have significantly improved shock control; however, many patients still die after septic shock reversal. We conducted a retrospective review to examine in-hospital death in whom shock was reversed and vasopressor was discontinued for 72 hours or longer. Factors independently associated with death were determined. Medical records of septic shock survivors from the medical intensive care unit of the Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, during January 2012-January 2019 were analyzed. A total of 350 septic shock patients were enrolled. Of these, 280 survived initial resuscitation. Eighty of 280 patients died, 45 died by 28 days (16.1%), and 35 (12.5%) died thereafter during their hospital stay. Multi-organ failure and hospital-acquired pneumonia (HAP) were the leading causes of death, followed by other infection and noninfectious complication. Although the death group had more laboratory derangement and required more organ support, there were four factors associated with mortality from multivariate analysis. Hospital-acquired pneumonia was the leading factor, followed by sequential organ failure assessment score and serum albumin at 72 hours after discontinuation of vasopressors, and total intravenous fluid during 72 hours after discontinuation of vasopressors. In-hospital mortality after hemodynamic restoration in patients with septic shock was substantial. Causes and contributing factors were identified. Measures to mitigate these risks would be beneficial for rendering more favorable patient outcomes.

摘要

在脓毒症复苏方面的进展显著改善了休克的控制;然而,许多患者在脓毒性休克逆转后仍死亡。我们进行了一项回顾性研究,以检查在休克逆转和停用血管加压素 72 小时或更长时间的患者中院内死亡的情况。确定了与死亡独立相关的因素。对 2012 年 1 月至 2019 年 1 月期间,泰国玛希隆大学诗里拉吉医院内科重症监护病房的脓毒症休克幸存者的病历进行了分析。共纳入 350 例脓毒症休克患者。其中,280 例初始复苏存活。280 例患者中有 80 例死亡,45 例在 28 天内死亡(16.1%),35 例(12.5%)在住院期间随后死亡。多器官衰竭和医院获得性肺炎(HAP)是主要死亡原因,其次是其他感染和非感染性并发症。尽管死亡组的实验室指标更紊乱,需要更多的器官支持,但多变量分析显示有 4 个因素与死亡率相关。医院获得性肺炎是主要因素,其次是序贯器官衰竭评估评分和停用血管加压素后 72 小时的血清白蛋白以及停用血管加压素后 72 小时的总静脉输液量。在脓毒性休克患者血流动力学恢复后,院内死亡率仍然很高。确定了病因和促成因素。采取措施减轻这些风险将有利于改善患者预后。

相似文献

10

引用本文的文献

1
Shock epidemiology and outcomes among internal medicine patients.内科患者的休克流行病学及预后
South Afr J Crit Care. 2025 May 19;41(1):e2453. doi: 10.7196/SAJCC.2025.v41i1.2453. eCollection 2025.
4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验